1. Home
  2. PROF vs SCD Comparison

PROF vs SCD Comparison

Compare PROF & SCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROF
  • SCD
  • Stock Information
  • Founded
  • PROF N/A
  • SCD 2003
  • Country
  • PROF Canada
  • SCD United States
  • Employees
  • PROF N/A
  • SCD N/A
  • Industry
  • PROF Medical/Dental Instruments
  • SCD Trusts Except Educational Religious and Charitable
  • Sector
  • PROF Health Care
  • SCD Finance
  • Exchange
  • PROF Nasdaq
  • SCD Nasdaq
  • Market Cap
  • PROF 186.3M
  • SCD N/A
  • IPO Year
  • PROF N/A
  • SCD N/A
  • Fundamental
  • Price
  • PROF $7.24
  • SCD $16.71
  • Analyst Decision
  • PROF Strong Buy
  • SCD
  • Analyst Count
  • PROF 2
  • SCD 0
  • Target Price
  • PROF $11.40
  • SCD N/A
  • AVG Volume (30 Days)
  • PROF 105.6K
  • SCD 62.6K
  • Earning Date
  • PROF 11-07-2024
  • SCD 01-01-0001
  • Dividend Yield
  • PROF N/A
  • SCD 9.63%
  • EPS Growth
  • PROF N/A
  • SCD N/A
  • EPS
  • PROF N/A
  • SCD N/A
  • Revenue
  • PROF $8,984,000.00
  • SCD N/A
  • Revenue This Year
  • PROF $56.61
  • SCD N/A
  • Revenue Next Year
  • PROF $160.87
  • SCD N/A
  • P/E Ratio
  • PROF N/A
  • SCD N/A
  • Revenue Growth
  • PROF 39.35
  • SCD N/A
  • 52 Week Low
  • PROF $6.88
  • SCD $11.33
  • 52 Week High
  • PROF $11.42
  • SCD $15.87
  • Technical
  • Relative Strength Index (RSI)
  • PROF 40.10
  • SCD 36.96
  • Support Level
  • PROF $7.00
  • SCD $17.45
  • Resistance Level
  • PROF $7.40
  • SCD $17.79
  • Average True Range (ATR)
  • PROF 0.40
  • SCD 0.37
  • MACD
  • PROF -0.07
  • SCD -0.14
  • Stochastic Oscillator
  • PROF 15.52
  • SCD 20.65

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: